Keratin 8 variants are associated with cryptogenic hepatitis

2012 ◽  
Vol 460 (4) ◽  
pp. 389-397 ◽  
Author(s):  
Mario Zierden ◽  
Arndt-Hendrik Penner ◽  
Manuel Montesinos-Rongen ◽  
Maren Weferling ◽  
Uta Drebber ◽  
...  
2011 ◽  
Vol 49 (01) ◽  
Author(s):  
M Zierden ◽  
A Penner ◽  
M Montesinos-Rongen ◽  
M Weferling ◽  
U Drebber ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A45-A45
Author(s):  
N KU ◽  
R GISH ◽  
T WRIGHT ◽  
M OMARY
Keyword(s):  

2014 ◽  
Vol 52 (01) ◽  
Author(s):  
N Guldiken ◽  
Q Zhou ◽  
O Kucukoglu ◽  
M Rehm ◽  
LP James ◽  
...  

2015 ◽  
Vol 41 (08) ◽  
Author(s):  
J Halangk ◽  
T Berg ◽  
G Puhl ◽  
T Müller ◽  
O Landt ◽  
...  
Keyword(s):  

2012 ◽  
Vol 21 (5) ◽  
pp. 1117-1123 ◽  
Author(s):  
Li Zhang ◽  
Boyu Zhang ◽  
Sang Jun Han ◽  
Amy N. Shore ◽  
Jeffrey M. Rosen ◽  
...  

2021 ◽  
Vol 22 (12) ◽  
pp. 6401
Author(s):  
Younglan Lim ◽  
Nam-On Ku

Although hepatocellular carcinoma (HCC) is developed with various etiologies, protection of hepatocytes seems basically essential to prevent the incidence of HCC. Keratin 8 and keratin 18 (K8/K18) are cytoskeletal intermediate filament proteins that are expressed in hepatocytes. They maintain the cell shape and protect cells under stress conditions. Their protective roles in liver damage have been described in studies of mouse models, and K8/K18 mutation frequency in liver patients. Interestingly, K8/K18 bind to signaling proteins such as transcription factors and protein kinases involved in HCC development. Since K8/K18 are abundant cytoskeletal proteins, K8/K18 binding with the signaling factors can alter the availability of the factors. Herein, we discuss the potential roles of K8/K18 in HCC development.


Sign in / Sign up

Export Citation Format

Share Document